• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国乳腺癌临床试验的文化适应性共享决策工具:一种由护士主导的方法。

Culturally Adapted Shared Decision-Making Tool for Breast Cancer Clinical Trials in China: A Nurse-Led Approach.

作者信息

Lu Ting, Xu Junxia, Cao Qingrong, Zhang Jing, Chen Jian, Lin Lin, Shan Benjie, Wei Jie

机构信息

Department of Comprehensive Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China.

出版信息

J Cancer Educ. 2025 May 15. doi: 10.1007/s13187-025-02646-7.

DOI:10.1007/s13187-025-02646-7
PMID:40369337
Abstract

This study aimed to develop and validate a culturally adapted, nurse-led shared decision-making question prompt list (SDM-QPL) to enhance decision-making support for Chinese breast cancer patients considering clinical trials. A mixed-methods approach was employed, involving a systematic literature review (52 studies), semi-structured interviews with 15 patients and 8 healthcare providers, a three-round Delphi consensus with 13 experts, and psychometric testing. The process yielded a 40-item QPL tailored to cultural needs, such as familial decision-making and Traditional Chinese Medicine (TCM) use. The SDM-QPL, organized into five modules, achieved strong expert consensus (Kendall's W = 0.82, P < 0.001) and retained 92% of nurse-sensitive items. Psychometric evaluation confirmed high validity (S-CVI/Ave = 0.89) and reliability (Cronbach's α = 0.91). Qualitative analysis identified key barriers: information overload (93.3%), risk misperceptions (86.7%), and nursing communication gaps (80.0%). This nurse-led SDM-QPL, grounded in Elwyn's Three-Talk Model, addresses China's unique cultural and structural challenges, fostering triadic dialogue among patients, families, and providers. The tool empowers oncology nurses to bridge communication gaps, improve trial participation equity, and support patient-centered care in collectivist settings.

摘要

本研究旨在开发并验证一种经过文化调适、由护士主导的共同决策问题提示清单(SDM-QPL),以加强对考虑参加临床试验的中国乳腺癌患者的决策支持。采用了混合方法,包括系统文献综述(52项研究)、对15名患者和8名医疗服务提供者进行半结构化访谈、与13名专家进行三轮德尔菲共识法以及心理测量测试。该过程产生了一份针对文化需求(如家庭决策和中医使用)量身定制的包含40个条目的QPL。SDM-QPL分为五个模块,达成了强烈的专家共识(肯德尔和谐系数W = 0.82,P < 0.001),并保留了92%的护士敏感条目。心理测量评估证实其具有高有效性(S-CVI/Ave = 0.89)和可靠性(克朗巴哈α系数 = 0.91)。定性分析确定了关键障碍:信息过载(93.3%)、风险认知错误(86.7%)和护理沟通差距(80.0%)。这种由护士主导的SDM-QPL以埃尔温的“三谈”模型为基础,应对了中国独特的文化和结构挑战,促进了患者、家庭和医疗服务提供者之间的三方对话。该工具使肿瘤护理人员能够弥合沟通差距,提高试验参与的公平性,并在集体主义环境中支持以患者为中心的护理。

相似文献

1
Culturally Adapted Shared Decision-Making Tool for Breast Cancer Clinical Trials in China: A Nurse-Led Approach.中国乳腺癌临床试验的文化适应性共享决策工具:一种由护士主导的方法。
J Cancer Educ. 2025 May 15. doi: 10.1007/s13187-025-02646-7.
2
A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.对所有医疗环境中共同决策的内部和外部影响进行的定性系统评价。
JBI Libr Syst Rev. 2012;10(58):4633-4646. doi: 10.11124/jbisrir-2012-432.
3
Measuring readiness for nurse-led shared decision making in clinical practice: development and first testing of the RSDM-N scale.衡量临床实践中护士主导的共同决策准备情况:RSDM-N量表的开发与首次测试
BMC Nurs. 2025 Apr 14;24(1):417. doi: 10.1186/s12912-025-03070-4.
4
Enhancing decision making about participation in cancer clinical trials: development of a question prompt list.提高癌症临床试验参与决策:问题提示清单的制定。
Support Care Cancer. 2011 Aug;19(8):1227-38. doi: 10.1007/s00520-010-0942-6. Epub 2010 Jul 1.
5
Development and validation of a question prompt list for parents of children with attention-deficit/hyperactivity disorder: a Delphi study.注意缺陷多动障碍患儿家长问题提示清单的开发与验证:一项德尔菲研究
Health Expect. 2016 Apr;19(2):234-52. doi: 10.1111/hex.12341. Epub 2015 Jan 19.
6
Development and psychometric properties of the nursing ethical decision-making ability scale.护理伦理决策能力量表的编制及心理测量学特性
BMC Med Ethics. 2025 Mar 14;26(1):35. doi: 10.1186/s12910-025-01190-9.
7
Cultural adaptation of a shared decision making tool with Aboriginal women: a qualitative study.针对原住民女性的共同决策工具的文化适应性:一项定性研究。
BMC Med Inform Decis Mak. 2015 Jan 28;15:1. doi: 10.1186/s12911-015-0129-7.
8
Toward Shared Decision-Making in Degenerative Cervical Myelopathy: Protocol for a Mixed Methods Study.迈向退行性颈椎脊髓病的共同决策:一项混合方法研究的方案
JMIR Res Protoc. 2023 Oct 9;12:e46809. doi: 10.2196/46809.
9
Evaluation of reliability and validity regarding the Chinese version of Critical Cultural Competence Scale for clinical nurses.临床护士关键文化能力量表中文版的信度和效度评价。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Oct 28;47(10):1425-1434. doi: 10.11817/j.issn.1672-7347.2022.210695.
10
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study.当癌症治疗出现耐药时帮助患者与肿瘤学家沟通:开发、测试和实施患者沟通辅助工具的序贯协作混合方法研究。
JMIR Res Protoc. 2022 Jan 12;11(1):e26414. doi: 10.2196/26414.

本文引用的文献

1
Examining cancer patient preferences during three stages of decision making and family involvement: a multicenter survey study in China.在中国进行的一项多中心调查研究:考察癌症患者在三个决策阶段的偏好及家庭参与情况。
BMC Med Inform Decis Mak. 2025 Jan 7;25(1):9. doi: 10.1186/s12911-024-02846-z.
2
Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study.意大利肿瘤护士对参与临床试验的自我认知态度:一项队列观察性研究。
Tumori. 2024 Dec;110(6):443-450. doi: 10.1177/03008916241290736. Epub 2024 Oct 27.
3
Involvement of family members of older patients with cancer in triadic decision-making processes during medical consultations on an outpatient ward - an observational exploratory study using quantitative and qualitative methods.
参与癌症老年患者的家庭成员在门诊病房医疗咨询中的三方决策过程-使用定量和定性方法的观察性探索性研究。
J Geriatr Oncol. 2024 Mar;15(2):101699. doi: 10.1016/j.jgo.2023.101699. Epub 2024 Jan 12.
4
Acceptance Factors and Psychological Investigation of Clinical Trials in Cancer Patients.癌症患者临床试验的接受因素和心理调查。
Behav Neurol. 2023 Nov 24;2023:5617575. doi: 10.1155/2023/5617575. eCollection 2023.
5
Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials.超越参与:评估患者在肿瘤临床试验设计中的作用。
Curr Oncol. 2023 Sep 8;30(9):8310-8327. doi: 10.3390/curroncol30090603.
6
Decisional conflict and its determinants among patients with cancer undergoing immunotherapy combined with chemotherapy or targeted therapy: a cross-sectional study.癌症患者在接受免疫治疗联合化疗或靶向治疗时的决策冲突及其决定因素:一项横断面研究。
Sci Rep. 2023 Aug 5;13(1):12715. doi: 10.1038/s41598-023-39280-6.
7
Informed consent in cancer clinical drug trials in China: a narrative literature review of the past 20 years.中国癌症临床药物试验中的知情同意:对过去 20 年的叙述性文献回顾。
Trials. 2023 Jul 7;24(1):445. doi: 10.1186/s13063-023-07482-y.
8
Disparities in clinical trial participation in ovarian cancer: A real-world analysis.卵巢癌临床试验参与中的差异:真实世界分析。
Gynecol Oncol. 2023 Aug;175:25-31. doi: 10.1016/j.ygyno.2023.05.066. Epub 2023 Jun 8.
9
Disparity in Clinical Trial Participation Among Patients with Gastrointestinal Cancer.胃肠道癌患者参与临床试验的差异
J Am Coll Surg. 2022 Apr 1;234(4):589-598. doi: 10.1097/XCS.0000000000000129.
10
20th Anniversary Update of the Ottawa Decision Support Framework: Part 2 Subanalysis of a Systematic Review of Patient Decision Aids.渥太华决策支持框架 20 周年更新:第 2 部分:患者决策辅助工具系统评价的子分析。
Med Decis Making. 2020 May;40(4):522-539. doi: 10.1177/0272989X20924645. Epub 2020 Jun 10.